Trial Profile
An Exploratory Safety Study of 480 Biomedical Sinus Drug Depot in Adult Subjects With Chronic Sinusitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Chronic sinusitis; Rhinosinusitis
- Focus Adverse reactions
- Sponsors Lyra Therapeutics
- 10 Sep 2020 According to a Lyra Therapeutics media release, data from this study were presented at the 66th Annual Meeting of the American Rhinologic Society (ARS), taking place as a virtual event this week.
- 10 Sep 2020 Results published in the Lyra Therapeutics Media Release
- 08 Oct 2018 According to a Lyra Therapeutics media release, Richard Douglas, M.D. (Professor of Surgery at The University of Auckland, New Zealand), is the lead investigator of this trial.